Trial aims to extend remission for children treated with T-cell immunotherapy for leukemia – Medical Xpress
|
Trial aims to extend remission for children treated with T-cell immunotherapy for leukemia
Medical Xpress After phase 1 results of Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) trial have shown T-cell immunotherapy to be effective in getting 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) into … |
